3D Medical Devices Animations

Painless, Non-Invasive And Inexpensive Test For Colon Cancer
People are often reluctant to undergo a routine but painful colonoscopy - but the consequences can be fatal. According to the American Cancer Society, colon cancer is the third most common cancer found in American men and women and kills about 50,000 Americans every year. "85% of those who develop colon cancer have no symptoms or family history," says Prof. Nadir Arber, a professor of medicine and gastroenterology, at Tel Aviv University's Sackler Faculty of Medicine.

MAKOplasty(R) Robotic Arm Partial Knee Resurfacing -- A New Level Of Precision
A live surgical webcast of MAKOplasty(R) robotic arm partial knee resurfacing will be presented by Thomas M. Coon, M.D. and St. Elizabeth Community Hospital on December 1st at 3:00 p.m. PST. MAKOplasty(R) is a new, minimally invasive partial knee resurfacing procedure used to treat early to mid-stage knee osteoarthritis that offers a more precise and consistent result that can provide relief.

Laparoscopic Heller Myotomy Esophagea A Minimally Invasive Surgery To Treat Achalasia
OR-Live Webcast From Northwestern Memorial Hospital: December 2, 2008, 3:00 PM CST. Achalasia is a rare esophageal disease that effects thousands of people in the United States, most of whom are in their 20s to 50s, and often presents symptoms that mimic those of acid reflux, such as difficulty swallowing, heart burn and chest pain.

FDA 510(k) Clinical Trial Progress For AppyScore, World's First Blood-Based Diagnostic Test For Human Appendicitis
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, reported the enrollment level in the ongoing FDA 510(k) clinical trial for AppyScore(TM), the world's first blood-based diagnostic test for human appendicitis exceeds 700 patients.

Trellis(R) Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
Clinical data from a prospective registry presented this week at the 35th Annual Veith Symposium shows DVT treatment with the Trellis(R) Peripheral Infusion System from Bacchus Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most patients in about 20 minutes. This technique, called isolated pharmacomechanical thrombolysis, restores blood flow more quickly and safely than current catheter-directed thrombolysis (CDT) techniques.

Innovative Drugs-of-Abuse Testing System Announced By Philips And Concateno
Concateno plc, Europe's largest provider of drug and alcohol testing programmes, and Royal Philips Electronics (NYSE:PHG, AEX:PHI) have today announced an innovative handheld drugs-of-abuse detection device. Concateno-Philips pioneering system will make testing for drugs such as cocaine and heroin quicker, simpler and easier enabling immediate point-of-care drug test results, similar to current alcohol tests.

Successfull Completion Of Phase I Development Of In Vivo Glucose Sensing RFID Microchip
VeriChip Corporation ("VeriChip") (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that a significant milestone has been achieved toward the development of an in vivo glucose-sensing RFID microchip.

Gore Receives Approval To Market GORE EXCLUDER(R) AAA Endoprosthesis And GORE TAG(R) Thoracic Endoprosthesis In Canada
W. L. Gore & Associates (Gore) today announced at the 35th annual VEITHsymposium™ in New York that it has received regulatory clearance from Health Canada's Therapeutic Products Directorate to market the GORE EXCLUDER AAA Endoprosthesis and GORE TAG Thoracic Endoprosthesis in Canada. Planning is underway for Canadian physician training on the devices, and the subsequent commercial product release timeline will be announced in the near future.

Depuy Mitek Launches Healix™ Br With Biocryl(R) Rapide™, Leading U.S. Biocomposite Material For Shoulder, Knee Implants
DePuy Mitek, Inc., a leading orthopedics sports medicine company, today announced the launch of the HEALIX™ BR Dual Threaded Anchor System, the first suture anchor for arthroscopic rotator cuff repair made with the company's proprietary BIOCRYL® RAPIDE™ biocomposite material, shown in pre-clinical trials to resorb and promote bone formation within the implant profile2.

Invitrogen Launches In Vivo RNAi Delivery Reagent - Products To Simplify And Enable Research On All Sequencing Platforms
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of its Invivofectamine™ delivery reagent which enables short interference ribonucleic acid (siRNA) experiments in vivo. The study of RNA interference (RNAi) has revolutionized biology by allowing researchers to directly observe the effects of the loss of function of specific genes in mammalian systems.

Pocket-Sized Echocardiograph Provides Quick And Qualitative Assessment
The European Journal of Echocardiography* recently published a paper studying the performance of Siemens' ACUSON P10™ ultrasound system at the Morriston Cardiac Centre in Swansea. Results revealed that the P10 was, within a four minute examination, able to assess the size and function of the left ventricle in more than three quarters of cardiac patients.

Flexible Electronics For Medical Sensors
They've made electronics that can bend. They've made electronics that can stretch. And now, they've reached the ultimate goal -- electronics that can be subjected to any complex deformation, including twisting.

Medtronic Launches New Medical Device In U.S. To Improve Treatment Of Aortic Aneurysms
Adding to its recent endovascular aortic repair (EVAR) innovations, Medtronic, Inc. (NYSE: MDT), today announced the U.S. launch of the Talent Abdominal Stent Graft on the Xcelerant Hydro Delivery System. EVAR is a treatment for aortic aneurysm, a dangerous bulge or weakening in the body's main artery that can rupture with fatal consequences if left untreated.

American Teenager Survives 4 Months Without Heart
A 14-year old American girl was kept alive for 118 days without a heart while waiting for a second heart transplant at a hospital in Florida; surgeons fitted a custom-made artificial heart after removing the first transplanted heart in July this year. D'Zhana Simmons, who lives in South Carolina, had her first heart transplant on 2nd July at Holtz Children's Hospital at the University of Miami/Jackson Memorial Medical Center.

FDA Approves Lumen Biomedical's FiberNet Embolic Protection System For Carotid Artery Stenting
Lumen Biomedical, Inc. (Plymouth, MN) announced today that the U.S. Food and Drug Administration (FDA) has cleared its FiberNet® Embolic Protection System (EPS) for the treatment of patients receiving endovascular intervention for carotid artery disease. The approval follows the recent release of the EPIC Clinical Study data demonstrating the lowest stroke rates of any filter currently available on the US market.